Multiple sclerosis : clinical and laboratory research
-
Randomized Controlled Trial Multicenter Study
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Steroids improve multiple sclerosis (MS) relapses but therapeutic window and dose, frequency and administration route remain uncertain. ⋯ This study provides confirmatory evidence that oMP is not inferior to ivMP in reducing EDSS, similar in MRI lesions at four weeks for MS relapses and is equally well tolerated and safe.